Decheng Capital
Healthcare investment firm3000 Sand Hill Road, USASee on the mapdecheng.com
Health specialist
Decheng Capital is a global life sciences investment firm providing capital and strategic support to early-stage life science companies and growth-stage healthcare companies.
- 2
- Portfolio companies on reccy
- 0
- Hiring now
- 0
- Open roles in the portfolio
- Jul 2021
- Latest portfolio round
Hiring now in the portfolio0
Apply on each company's siteNone of their companies on reccy has an open role right now. Browse all neurotech roles
Portfolio on reccy2
From company funding recordsTheir companies, round by round
From company funding records- Shape TherapeuticsSeattle, Washington, United States
- Jul 2026Grant
- Jul 2021Series B · $112MLed
- Nov 2019Series A · $35.5M
- Jan 2019Spinoff / Spinout
- Nalu MedicalCarlsbad, California
Neuromodulation
- UndatedDebt Financing
- UndatedVenture Round
- UndatedSeries E
Rounds marked Led list Decheng Capital as a lead investor; the rest are the company's other funding.
Recent rounds in the portfolio
- Jul 2021
Shape Therapeutics · Series B $112MLead
With Breton Capital Management, New Enterprise Associates, Cherubic Ventures, Mission BioCapital, CureDuchenne Ventures, Highbury Group, Sofinnova Investments, VZVC, Willett Advisors, 8VC, Menlo Ventures, Breton Capital Ventures
Portfolio in the news
From the Cortex · last 12 months- Feb 2026Boston Scientific Exec on $533M Nalu Medical Acquisition
Nalu Medical · Medical Device and Diagnostic industry
- Jan 2026Boston Scientific closes $533m acquisition of Nalu Medical
Nalu Medical · med-techinsights.com
- Jan 2026
- Jan 2026
- Jan 2026
- Jan 2026